Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT00930462




Registration number
NCT00930462
Ethics application status
Date submitted
26/06/2009
Date registered
30/06/2009
Date last updated
30/06/2009

Titles & IDs
Public title
Evaluation of the Use of Cap in Improving the Performance of Colonoscopy
Scientific title
A Prospective Randomised Controlled Trial Comparing Cap-Assisted Colonoscopy Versus Standard Colonoscopy
Secondary ID [1] 0 0
X07-0107
Secondary ID [2] 0 0
CAPCOLON
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Colonoscopy 0 0
Condition category
Condition code

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Cap (Olympus Medical Systems: D-201-15004, D-201-14304 and D-201-12704)

No Intervention: Conventional colonoscopy - No cap fitted on the colonoscopes for this group.

Experimental: Cap-assisted colonoscopy -


Treatment: Devices: Cap (Olympus Medical Systems: D-201-15004, D-201-14304 and D-201-12704)
Plastic cap fitted on the colonoscope
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Time to cecum
Timepoint [1] 0 0
One month
Secondary outcome [1] 0 0
Polyp detection rate
Timepoint [1] 0 0
One month

Eligibility
Key inclusion criteria
- All colonoscopy patients referred for colonoscopy at Royal Prince Alfred Hospital.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Prior colonic resection

- Pregnancy.

- Severe co-morbidities.

- Tertiary referral for endo-mucosal resection.

- Acute surgical conditions such as severe colitis, toxic megacolon, ischemic colitis,
acute gastrointestinal bleeding.

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?
The people receiving the treatment/s


Intervention assignment
Parallel
Other design features
Phase
Phase 4
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/03/2008
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/02/2009
Sample size
Target
Accrual to date
Final
400
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Royal Prince Alfred Hospital - Sydney
Recruitment postcode(s) [1] 0 0
- Sydney

Funding & Sponsors
Primary sponsor type
Other
Name
Royal Prince Alfred Hospital, Sydney, Australia
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The aim of this study is to compare the colonoscopy success rate, cecal time and polyp
detection rate between cap-fitted colonoscopy and conventional colonoscopy.
Trial website
https://clinicaltrials.gov/ct2/show/NCT00930462
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Arthur J Kaffes, FRACP
Address 0 0
Royal Prince Alfred Hospital, Sydney
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT00930462